SCHEMBL475188

SCHEMBL475188

NCC(N)CS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8105249 1.00
SCHEMBL346804 0.79
SCHEMBL68116 0.74
SCHEMBL11379748 0.72
Hydrochloric Acid SCHEMBL11080238 0.70
SCHEMBL14198852 0.67
SCHEMBL653873 0.67 ALDH1A1 (0.40)
Iodide SCHEMBL3135770 0.67 ALDH1A1 (0.40)
SCHEMBL19832276 0.67
SCHEMBL15167041 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046235-A9 Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2012-02-23 US claimed
EP-1933878-B1 CONJUGATES OF HYDROXYALKYL STARCH AND AN ACTIVE SUBSTANCE, PREPARED BY CHEMICAL LIGATION VIA THIAZOLIDINE FRESENIUS KABI DE GMBH (DE) 2012-02-01 EP claimed
EP-2279752-A2 Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation Fresenius Kabi Deutschland GmbH (DE) 2011-02-02 EP claimed
US-20100311670-A1 Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2010-12-09 US claimed
US-20080207562-A1 Conjugates of Hydroxyalkyl Starch and Active Substance, Prepared by Chemical Ligation Via Thiazolidine FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2008-08-28 US claimed
EP-1762250-A1 Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine Fresenius Kabi Deutschland GmbH (DE) 2007-03-14 EP claimed
US-6011175-A Inhibition of farnesyltransferase UNIVERSITY OF PITTSBURGH (US) 2000-01-04 US claimed
US-5965539-A PEPTIDOMIMETICS; ANTI-CANCER DRUGS UNIVERISTY OF PITTSBURGH (US) 1999-10-12 US claimed
EP-0794789-A4 INHIBITORS OF PRENYL TRANSFERASES UNIV PITTSBURGH (US) 1999-05-26 EP claimed
US-5834434-A PEPTIDOMIMETICS UNIVERSITY OF PITTSBURGH (US) 1998-11-10 US claimed
US-5705686-A 3-MERCAPTO-2-AMINO-PROPYLAMINOBIPHENYL DERIVATIVES; PEPTIDOMIMETICS; ANTICARCINOGENIC AGENTS UNIVERSITY OF PITTSBURGH (US) 1998-01-06 US claimed
EP-0794789-A1 INHIBITORS OF PRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1997-09-17 EP claimed
WO-1996021456-A1 INHIBITORS OF PRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1996-07-18 WO claimed
US-20220179311-A1 CURABLE COMPOSITION, CURED PRODUCT, COLOR FILTER, SOLID-STATE IMAGING ELEMENT, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2022-06-09 US disclosed
US-20120046235-A9 Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2012-02-23 US disclosed
EP-1933878-B1 CONJUGATES OF HYDROXYALKYL STARCH AND AN ACTIVE SUBSTANCE, PREPARED BY CHEMICAL LIGATION VIA THIAZOLIDINE FRESENIUS KABI DE GMBH (DE) 2012-02-01 EP disclosed
EP-0576915-B1 cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders SIGMA TAU IND FARMACEUTI (IT) 1997-04-16 EP disclosed
US-5593982-A SUCH AS HEART FAILURE AND HYPERTENSION SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1997-01-14 US disclosed
US-5432169-A Cyclopentanperhydrophenanthren-17β-(3-furyl)-3-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1995-07-11 US disclosed
EP-0576915-A2 cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1994-01-05 EP disclosed